Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | opioid receptor, delta 1 | Starlite/ChEMBL | References |
Homo sapiens | opioid receptor, kappa 1 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | References |
Homo sapiens | opioid receptor, mu 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tm gpcr rhodopsin | Get druggable targets OG5_139759 | All targets in OG5_139759 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | Get druggable targets OG5_139759 | All targets in OG5_139759 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | glycogen phosphorylase | 0.451 | 1 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.451 | 1 | 1 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.451 | 1 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.451 | 1 | 1 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.195 | 0.3396 | 0.5 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.451 | 1 | 0.5 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.451 | 1 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.451 | 1 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.451 | 1 | 1 |
Giardia lamblia | Glycogen phosphorylase | 0.451 | 1 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.451 | 1 | 1 |
Echinococcus granulosus | glycogen phosphorylase | 0.451 | 1 | 1 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.451 | 1 | 0.5 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.195 | 0.3396 | 0.5 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.451 | 1 | 0.5 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.451 | 1 | 1 |
Echinococcus granulosus | glycogen phosphorylase | 0.451 | 1 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.451 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 32 nM | Agonist activity assessed by ability to stimulate [35S]-GTP gammaS binding to opioid receptor kappa in human membranes | ChEMBL. | 15863335 |
EC50 (functional) | = 32 nM | Agonist activity assessed by ability to stimulate [35S]-GTP gammaS binding to opioid receptor kappa in human membranes | ChEMBL. | 15863335 |
IC50 (ADMET) | = 1820 nM | Inhibiton of cytochrome P450 2D6 was determined using MAMC (7-methoxy-4-aminomethyl-coumarin) as substrate | ChEMBL. | 15863335 |
IC50 (ADMET) | = 1820 nM | Inhibiton of cytochrome P450 2D6 was determined using MAMC (7-methoxy-4-aminomethyl-coumarin) as substrate | ChEMBL. | 15863335 |
Ki (binding) | = 10 nM | Inhibitory constant against human Opioid receptor kappa using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Ki (binding) | = 10 nM | Inhibitory constant against human Opioid receptor kappa using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Ki (binding) | = 1500 nM | Inhibitory constant against human Opioid receptor delta 1 using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Ki (binding) | = 1500 nM | Inhibitory constant against human Opioid receptor delta 1 using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Ki (binding) | = 1900 nM | Inhibitory constant against human Opioid receptor mu 1 using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Ki (binding) | = 1900 nM | Inhibitory constant against human Opioid receptor mu 1 using [3H]-diprenorphine as radio ligand | ChEMBL. | 15863335 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.